CPMC Research Institute Active Addiction and Pharmacology Research Clinical Trials

Clinical Research Addiction and Pharmacology Research (APRL)

Open Trials | Trials Coming Soon | APRL's Main Page

Principal Investigator/Contact Information	Protocol Title	Patient Population	Recruitment Period
Principal Investigator: Gantt Galloway, PharmD Contact: Jennifer Siegrist 415-641-3370 Email APRL	Phase II Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence Visit the Bupropion for Methamphetamine Dependence study on ClinicalTrials.gov.	Males and Females ages 18-65 that use methamphetamine and want to quit. Must be able to come in 3x per week for visits.	Open
Principal Investigator: Keith Flower, MD Contact: Jayme Mulkey 415 641 3370 Email APRL	A Pilot Trial of Naltrexone for Methamphetamine Addiction - Role of the A118G SNP Visit the Naltrexone for Methamphetamine Addiction study on ClinicalTrials.gov.	Males and Females ages 18-50 that use methamphetamine and want to quit	Open
Principal Investigator: Gantt P. Galloway PharmD Contact: Kathleen Garrison 415 641 3370 Email APRL	A Dose Ranging Study of Modafinil for Methamphetamine Dependence	Males and Females ages 18-50 that use methamphetamine and want to quit	Open

Principal Investigator/Contact Information	Protocol Title	Patient Population	Recruitment Period
Principal Investigator: Gantt Galloway, PharmD Contact: Margie Jang, NP 415-641-3370 Email APRL	A Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Lofexidine	Cocaine-experienced males and females aged 18-50 years. Must be able to be inpatient 10 nights and 11 days	Coming Soon
Principal Investigator: Linghui Li MD PhD & John Mendelson MD Contact: Linghui Li 415-641-3370 Email APRL	An Open-Label Study to Evaluate the Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine in Healthy Adults	Healthy males and females ages 18-55	Coming Soon